19 November 2024 Judges at Munich Local Division determined that Meril infringed Edwards Lifesciences’ patent | Meril ordered to stop selling and recall product as well as pay damages.
19 November 2024
14 November 2024
14 November 2024
14 November 2024
14 November 2024
Latest Features
Asia
Free trade zones in Beijing, Shanghai, Guangdong, and Hainan are designed to attract capital into China’s fast-growing healthcare sectors, says Li Mi of Lusheng.
Americas
Well-drafted contracts and ironclad tech security can save time and money when an ex-employee steals IP ‘like sugar packets in Starbucks’, finds Tom Phillips.
Asia
The Beijing IP court’s decision to revive a key semaglutide patent based on experimental data has far-reaching legal and economic implications, says Jennifer Che of Eagle IP
Asia
Recent updates to China’s patent law provide guidelines on PTA calculations, definitions of delays and challenging decisions, say Audrey Cheung, Yolanda Wang and Jennifer Che of Eagle IP.
Biotechnology
The shift towards preventative pharmaceuticals could open new, and highly valuable, markets but it must be strengthened by patent rights, says Sam Andrews, senior paralegal at Powell Gilbert.
Unified Patent Court
The court rejected the medical device company’s auxiliary requests and nixed patent in 17 territories although it seems receptive to these amendments in general, say Laura Orlando and Rachel Montagnon of Herbert Smith Freehills.
Unified Patent Court
A distinctive UPC approach to patent validity and revocations is emerging as the court shows its willingness to break new ground, say Emily Bottle and Sebastian Moore of HSF.
Americas
If adopted, the pending rule would reshape litigation strategy and offer patent defendants a valuable tool, say Kristen Lovin and Niall Frizzell of Keker, Van Nest & Peters
More News
14 November 2024 Transatlantic deal would make ‘HSF Kramer’ a top 20 global firm by revenue | ‘Transformational’ combination a ‘one-of-a-kind’ opportunity, say firms’ leaders | HSF Kramer would have 2,700 lawyers, including 640 partners across 25 offices | IP practice would have approximately 32 partners.
12 November 2024 Oral arguments heard in case between Teva and generics maker Amneal over inhaler patents | Teva says district court and Amneal asked court to ‘slice apart new drug application’.
12 November 2024 The patents have been officially revoked following the pair's voluntary decision to withdraw them | Withdrawal follows unfavourable preliminary opinion from the EPO | Cancelled patents not expected to impact ongoing licensing agreements for CRISPR technology, says licensor.
12 November 2024 Sapna Palla joins the firm in New York, bringing significant experience in complex life sciences and IP disputes to a growing practice.
7 November 2024 As Donald Trump celebrates a second term, LSIPR looks at how key IP areas could be affected ahead of his return to the Oval Office.
5 November 2024 A US biopharma firm must pay the damages to Sandoz over a long-running dispute over lung therapy | New Jersey district judge had ordered the pair to “meet and confer” in a September judgment, but the parties couldn’t agree.
5 November 2024 The 47th US president will need to address the thorny issues of non-competes, patent rights and drug pricing.
Get up-to-date information on all our publications and events
Get critical life sciences news direct to your inbox